SUBSCRIBE
SUBSCRIBE

Gina Hagler

Yoav Kimchy, founder and chief technology officer
Business
Let’s Get to Know Yoav Kimchy, Founder and Chief Technology Officer of Check-Cap
BioSpace recently spoke with Yoav Kimchy, founder and chief technology officer of Check-Cap, a company developing the C-Scan® system to detect precancerous polyps.
August 25, 2021
 · 
5 min read
 · 
Gina Hagler
James Oliviero, CEO and president of Checkpoint Th
Business
Get to Know James Oliviero, CEO and President of Checkpoint Therapeutics
BioSpace recently spoke with James Oliviero, CEO and president at Checkpoint Therapeutics, an immuno-oncology, late-stage development company.
August 11, 2021
 · 
4 min read
 · 
Gina Hagler
Business
Let’s Get to Know Mir Imran, CEO and Chief Innovator at Rani Therapeutics
BioSpace recently spoke with Mir Imran, CEO and Chief Innovator at Rani Therapeutics, a company developing and testing a “robotic” pill that delivers biologics orally.
June 9, 2021
 · 
5 min read
 · 
Gina Hagler
Business
Get to Know Jonathan Rigby, Group CEO of Revolo Biotherapeutics
BioSpace recently spoke with Jonathan Rigby, Group CEO of Revolo Biotherapeutics, a biotherapeutic company working to revolutionize the treatment of autoimmune and allergic disease by achieving superior long-term disease remission through resetting the immune system.
May 6, 2021
 · 
4 min read
 · 
Gina Hagler
Business
Get to Know Norman Sussman, Chief Medical Officer at DURECT
BioSpace recently spoke with Norman Sussman, chief medical officer at DURECT, a company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and lifesaving therapies based on its endogenous epigenetic regulator program.
April 22, 2021
 · 
3 min read
 · 
Gina Hagler
Business
Let’s Get to Know Paula Ragan, CEO and President of X4 Pharmaceuticals
BioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.
April 21, 2021
 · 
4 min read
 · 
Gina Hagler
Sanjeev Luther, CEO and Board Member of Rafael Pha
Business
Get to Know Sanjeev Luther, CEO and Board Member of Rafael Pharmaceuticals
BioSpace recently spoke with Sanjeev Luther, CEO and board member of Rafael Pharmaceuticals, a clinical-late stage metabolic therapeutics company.
March 17, 2021
 · 
3 min read
 · 
Gina Hagler
Photo courtesy of Kazia.
Business
Getting to Know Dr. James Garner, CEO of Kazia Therapeutics
BioSpace recently spoke with Dr. James Garner, CEO of Kazia Therapeutics, an oncology company that is focused on the development of cancer drugs.
November 12, 2020
 · 
5 min read
 · 
Gina Hagler
Business
AGT CEO Jeff Galvin on the Future of the Gene and Cell Therapy Industry
Jeff Galvin, CEO of American Gene Technologies (AGT), had 30 years of business and entrepreneurial experience in Silicon Valley during the formative years of the personal computing and internet era.
April 23, 2020
 · 
4 min read
 · 
Gina Hagler
REL-1017 can be a treatment of major depression th
Business
Relmada Therapeutics Developing REL-1017 to Treat Major Depression
Relmada Therapeutics is working to develop a treatment, REL-1017, for those with depression that do not respond to drugs currently on the market.
April 21, 2020
 · 
4 min read
 · 
Gina Hagler
Business
Flatten the Curve: COVID-19
‘Flatten the Curve’ is sure to become a phrase forever linked with COVID-19. It refers to doing all we can as individuals to slow the spread of COVID-19 so that all available resources can be used for those who need them most urgently.
March 17, 2020
 · 
4 min read
 · 
Gina Hagler
Business
A Look at Kazia’s Business Model with CEO James Garner
Kazia Therapeutics is company focused on developing anti-cancer drugs.
February 20, 2020
 · 
2 min read
 · 
Gina Hagler
Deal or No Deal: Uncertainty Surrounding Brexit Continues
The Withdrawal Agreement Bill passed in Britain’s House of Commons on Thursday, setting January 31st as the UK’s departure date from the EU, and potentially wrapping up one part of the three-year quagmire that is Brexit.
January 22, 2020
 · 
3 min read
 · 
Gina Hagler
Kena Betancur/Getty Images
Policy
The Lower Drug Costs Now Act of 2019 – The Numbers Behind the Claims
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (cited as the Lower Drug Costs Now Act of 2019), awaits a vote by the House in December.
December 11, 2019
 · 
4 min read
 · 
Gina Hagler
Business
The Lower Drug Costs Now Act of 2019 – What Stakeholders Have to Say
Just what do those in favor of the H.R. 3 - organizations, individuals, companies and institutions - have to say?
November 20, 2019
 · 
5 min read
 · 
Gina Hagler
Load More